COMMUNIQUÉS West-GlobeNewswire

MEDIA ADVISORY - Protests Against Ford Government’s Expanding Hospital Privatization Plans
22/09/2025
TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- “The Ford government is privatizing our public hospitals in a move that is costing patients thousands of dollars and taking away from our local public hospital services. [...]
API Launches the Life Sciences Placement Program in Partnership with Mitacs at the Life Sciences Week Kick-Offs
22/09/2025
EDMONTON, Alberta and CALGARY, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- This morning, at events in Edmonton and Calgary, Applied Pharmaceutical Innovation (API) proudly announced the launch of its new Life Sciences [...]
Fairhaven Health Develops Clinical Nutrition-Based Formulas to Support Women with PCOS and PMS
22/09/2025
MIDDLETOWN, Conn., Sept. 22, 2025 (GLOBE NEWSWIRE) -- During September’s PCOS Awareness Month, Fairhaven Health is drawing attention to the role targeted nutrition can play in supporting women affected by polycystic [...]
IBA – Transparency Notification
22/09/2025
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve (Belgium), 22 September 2025, 06:00 PM Summary of the notification IBA (Ion Beam Applications S.A - EURONEXT - [...]
IBA SA – NOTIFICATION TRANSPARENCE
22/09/2025
(Article 14, alinéa 1 er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve (Belgique), le 22 septembre 2025, 18h00 Résumé de la notification IBA (Ion Beam Applications S.A [...]
New mobile units to drive early breast cancer detection in Alberta
22/09/2025
Alberta Cancer Foundation and Primary Care Alberta bring life-saving breast cancer screening to women in rural and remote communities EDMONTON, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Breast cancer screening is now [...]
Guerbet : Change in General Management
22/09/2025
Change in General Management Villepinte France, September 22nd, 2025 : Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announces the appointment of Mr. Jérôme [...]
Guerbet : Evolution de la Direction Générale
22/09/2025
Evolution de la Direction Générale Villepinte, le 22 septembre 2025, 17h45 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce la nomination de [...]
Humanitarian Nonprofit Human Appeal Canada to Host Second Annual Comedy Tour
22/09/2025
Joy and Impact Unleashed as Comedy Tour Funds Critical Relief for Those in Need TORONTO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Humanitarian aid nonprofit, Human Appeal Canada , is kicking off their second annual comedy [...]
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
22/09/2025
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG105 1 , a pre-clinical investigational novel compound with broad potential to treat brain health diseases, [...]
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference
22/09/2025
InBrain Pharma to Present Long-Term Follow-Up Clinical Data from Its Phase I/II DIVE-I Trial in Parkinson’s Disease at the MDS 2025 Conference Lille, September 22, 2025 – InBrain Pharma, a company specialized in the [...]
Baylor Genetics to Showcase the Expanding Role and Clinical Value of Genetic Testing in Pediatric Neurology at the 2025 Child Neurology Society Annual Meeting
22/09/2025
Company will feature new data on genomic diagnosis in epilepsy, advocate for expanded testing access, and host a symposium on the evolving role of sequencing in patient care HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- [...]
Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management
22/09/2025
Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain management ROSELAND, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Milestone [...]
Celcuity to Present Results from the Pivotal Phase 3 VIKTORIA-1 Trial at the 2025 European Society for Medical Oncology (ESMO) Congress
22/09/2025
MINNEAPOLIS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that a late breaking abstract [...]
Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa
22/09/2025
Exploring potential partnerships and strategic opportunities for the Company’s stem cell therapy program in Alzheimer’s disease Alzheimer’s disease development program with positive data in successful Phase 1 and Phase [...]
PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes
22/09/2025
Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading [...]
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index
22/09/2025
CARLSBAD, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced [...]
WORK Medical Technology Group LTD Partners with Wuxi Branch of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine to Develop AI-Applications in Healthcare
22/09/2025
Hangzhou, China, Sept. 22, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) [...]
Fierce Biotech names Incyclix Bio a “Fierce 15” Biotech Company of 2025
22/09/2025
RESEARCH TRIANGLE PARK, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, today announced that Fierce Biotech has named it as one of 2025’s Fierce 15 biotechnology companies, designating it as one of the most [...]

Pages